shutterstock_1029115462_jose_l_stephens

Jose L. Stephens / Shutterstock.com

22 October 2019Americas

Event preview: Life Sciences IP Due Diligence summit

The continued success of a life sciences company hinges upon successful partnerships. There are many corporate transactions involving life sciences IP that necessitate conducting due diligence.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Gilead scores win in fake HIV drug dispute

Polsinelli grows roster with ex-corporate counsel

Sandoz wins $137.2m payout for lost profits in generic launch

Dexcom suffers second patent revocation at hands of UPC

Sanofi signs global rights deal to develop rare cancer therapy

WBD to merge with firm to create ‘powerhouse’ practice

Novo Nordisk files fresh lawsuits to intercept Wegovy generics

AstraZeneca unit draws line under Samsung dispute